Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Aisha Walker, PhD
Researcher Assistant Professor of Medicine
Division of Pulmonary,
Allergy and Critical Care Medicine
Vascular Medicine Institute
University of Pittsburgh
E1226-0A BST
200 Lothrop Street
Pittsburgh, Pennsylvania, United States
Dr. Walker is a Research Assistant Professor in the Vascular Medicine Institute at University of Pittsburgh. Dr. Walker is currently a Sickle Cell Scholar at Pitt. Her basic and translational research projects continue to investigate mechanisms related to pharmacologic therapies for sickle cell disease.
Dr. Walker’s primary research goal is to identify novel therapeutic strategies for the treatment of sickle cell disease (SCD). Her current projects are focused on identifying cellular and molecular modulators that mediate efficacy and toxicity of hydroxyurea, which is currently the only FDA approved drug for SCD. Dr. Walker’s work was the first to identify specific cell membrane transporters and microRNAs associated with the pharmacokinetics and clinical outcomes of hydroxyurea.
+myBinderRelated Content
-
How we treat delayed haemolytic transfusion reactions in patients with sickle cell diseaseTransfusion therapy is effective in the ...
-
Deepika Darbari, MDDr. Darbari is a pediatric hematologist ...
-
Barriers and Facilitators to Care for Individuals With Sickle Cell Disease in Central North Carolina: The Emergency ...Background: Sickle cell disease (SCD) i...
-
Sickle cell patient with severe anemia rapidly improves with voxelotor, case study showsGlobal Blood Therapeutics (GBT) reported...
-
Petition: Implement NIH Guidelines in Hospital Emergency Rooms when Managing a Sickle Cell CrisisHELP US REACH 1,500 E-SIGNATURES BY DECE...
-
Susan Claster, MDDr. Claster graduated from the Universit...
-
A Teenager’s Breakthrough Gene Therapy for Sickle Cell DiseaseMeet Helen Obando, a shy 16-year-old who...
